DIFFUSION NGF & BIOLOGICAL RESPONSE FROM BASAL FOREBRAIN CHOLINERGIC NEURONS
DIFFUSION NGF & BIOLOGICAL RESPONSE FROM BASAL FOREBRAIN CHOLINERGIC NEURONS
批准号:
6116643
负责人:
MARK H. TUSZYNSKI
金额:
$5.21万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2000-04-30
关键词:
中文摘要
神经生长因子调节基底前脑表型的意义
胆碱能神经元(BFCN),并可以促进BFCN的生存
损伤或与年龄相关的退化。 因此,NGF可能有助于
治疗阿尔茨海默氏症中神经元损失的胆碱能成分
疾病 然而,侧脑室注射神经生长因子,
非目标系统的重大不利影响;因此,
需要将NGF实质内递送到BFCN。 目的
确定脑实质内(IP)输注的NGF是否扩散,
距离足以引起广泛的神经营养作用,
灵长类、成年恒河猴(n=4)中的BFCN群体
7岁和19岁接受持续输注NGF [1.0
mg/ml x 12 ml/天]持续3天,注入纹状体或核中
大细胞基底层(NBM)。 对脑切片进行免疫标记,
NGF [Mufson等人,1994],并对CSF和血清样本进行检测
使用双位点ELISA测定NGF蛋白含量。 结果NGF递送IP
在6-10 mm范围内以球形分布扩散,
大部分NBM神经元。 只有少量的神经生长因子被检测到,
IP后的CSF。 因此,脑实质内
输注NGF广泛扩散,而仅升高CSF水平
微微 这些结果进一步支持了直接IP
输注可提供ICV输注的替代方案,
营养因子长期进入中枢神经系统。 关键词老龄化,
阿尔茨海默氏症,神经营养因子基金NIH Grant AG 10435
英文摘要
Significance NGF regulates the phenotype of basal forebrain
cholinergic neurons (BFCN) and can promote BFCN survival following
injury or age-related degeneration. NGF may therefore be useful in
treating the cholinergic component of neuronal loss in Alzheimer's
disease. However, intracerebroventricular infusions of NGF cause
substantial adverse effects from non-targeted systems; thus, local and
intraparenchymal delivery of NGF to BFCNs is necessary. Objectives To
determine whether intraparenchymal (IP) infusions of NGF diffuse for
distances sufficient to elicit neurotrophic effects from the extensive
population of BFCNs in the primate, adult rhesus monkeys (n=4) between
the ages of 7 and 19 years received continuous infusions of NGF [1.0
mg/ml x 12 ml/day] for 3 days into either the striatum or nucleus
basalis magnocellularis (NBM). Brain sections were immunolabeled for
NGF [Mufson et al., 1994], and CSF and serum samples were assayed for
NGF protein content using a two-site ELISA. Results NGF delivered IP
diffused in a spherical distribution over 6-10 mm and accessed a
majority of NBM neurons. Only slight amounts of NGF were detected in
the CSF after IP. Future Directions Thus, intraparenchymal brain
infusions of NGF diffuse extensively while raising CSF levels only
slightly. These results further support the concept that direct IP
infusions may provide an alternative to ICV infusions for delivering
trophic factors chronically into the CNS. KEY WORDS aging,
Alzheimer's, neurotrophic factor FUNDING NIH Grant AG10435
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing human neural progenitor cells (hNPCs) to FDA IND approval
-
批准号:10642228
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome - Supplement
-
批准号:10876189
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2023
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10663796
-
项目类别:
-
资助金额:$112.85万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10185291
-
项目类别:
-
资助金额:$120.15万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
-
批准号:10402369
-
项目类别:
-
资助金额:$114.19万
-
财政年份:2021
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
ShEEP request for a Zeiss LSM 880 with Airyscan confocal system
-
批准号:9573958
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10386916
-
项目类别:
-
资助金额:$63.63万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10211059
-
项目类别:
-
资助金额:$66.34万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The Primate Corticospinal Connectome and Transcriptome
-
批准号:10650134
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2017
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:10538563
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:9822285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
RR&D Gordon Mansfield Spinal Cord Injury Consortium
-
批准号:10322642
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:10267465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:9468259
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
The VA Gordon Mansfield SCI Consortium
-
批准号:8804160
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8927970
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8868875
-
项目类别:
-
资助金额:$86.19万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:9318419
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:8579707
-
项目类别:
-
资助金额:$119.42万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
-
批准号:9114022
-
项目类别:
-
资助金额:$92.55万
-
财政年份:2014
-
负责人:MARK H. TUSZYNSKI
-
依托单位:
海外基金